(Q46300079)

21 December 2017

title

Coumarin: an alternative candidate for the treatment of non-alcoholic steatohepatitis? (English)

1 reference

21 December 2017

non-alcoholic steatohepatitis

main subject

steatohepatitis

0 references

1 reference

1

1 reference

21 December 2017

publication date

23 January 2013

1 reference

21 December 2017

British Journal of Nutrition

published in

1 reference

21 December 2017

volume

109

1 reference

21 December 2017

issue

9

1 reference

21 December 2017

page(s)

1542-1543

1 reference

21 December 2017

Hepatoprotective and nitric oxide production inhibitory activities of coumarin and polyacetylene constituents from the roots of Angelica furcijuga

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512005806

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512005806

Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512005806

Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512005806

L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis--a randomized and controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512005806

Antioxidant role of coumarin on streptozotocin-nicotinamide-induced type 2 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512005806

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512005806

Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512005806

A safety assessment of coumarin taking into account species-specificity of toxicokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512005806

Physiologically based toxicokinetic modelling as a tool to assess target organ toxicity in route-to-route extrapolation--the case of coumarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512005806

Coumarin attenuates hepatic steatosis by down-regulating lipogenic gene expression in mice fed a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512005806

A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512005806

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1017/S0007114512005806

1 reference

21 December 2017

1 reference

21 December 2017